AI assistant

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

CYTOKINETICS INC Director's Dealing 2024

Jan 12, 2024

30870_dirs_2024-01-12_ff8d8063-1034-4d46-93af-7e1f19ec17a1.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: CYTOKINETICS INC (CYTK)
CIK: 0001061983
Period of Report: 2024-01-12

Reporting Person: HENDERSON JOHN T (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2024-01-12	Common Stock	M	5000	$4.44	Acquired	47632	Direct
2024-01-12	Common Stock	S	5000	$85.14	Disposed	42632	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2024-01-12	Non-Qualified Stock Option (Right to Buy)	$4.44	M	5000	Disposed	2024-05-21	Common Stock (5000)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	83	Indirect

Footnotes

F1: Transaction effected pursuant to a 10b5-1 plan meeting the requirements of Rule 10b5-1(c) under the Exchange Act entered into by the Reporting Person on September 18, 2023.